Literature DB >> 22631885

In vivo gene transfer in mouse preimplantation embryos after intraoviductal injection of plasmid DNA and subsequent in vivo electroporation.

Masahiro Sato1, Eri Akasaka, Issei Saitoh, Masato Ohtsuka, Satoshi Watanabe.   

Abstract

The aim of this study was to investigate whether direct injection of nonviral DNA into the oviductal lumen and subsequent in vivo electroporation leads to in vivo gene transfer in mouse preimplantation embryos present within an oviduct, as an alternative to the pre-existing pronuclear microinjection-based transgenesis. With this technique, effects of expression of the gene of interest (GOI) on mouse preimplantation development can be monitored with relative ease. Superovulated 4-week-old B6C3F1 female mice (hybrids between C57BL/6N and C3H/HeN) were mated with adult B6C3F1 male mice. Two days later, females that had been identified as pregnant, based on the presence of copulation plugs, were injected with 1 µl of a solution containing an enhanced green fluorescent protein (EGFP) expression plasmid (0.5 µg) and 0.05% trypan blue. The entire oviduct was then electroporated using tweezer-type electrodes with 8 square-wave pulses of 50 V each with 50-ms duration. The next day, the 8-cell stage embryos were collected, and their number, morphology, and EGFP-derived fluorescence were recorded. Of the 12 oviducts (6 females used) examined, 3 contained fluorescent 8-cell stage embryos (33%, 19/58 tested), but the intensity of fluorescence varied among the embryos. In total, 10% (19/192 tested) of the embryos were fluorescent and the fluorescence was maintained in these embryos after 1 day of culture. However, the fluorescence disappeared in the late gestational stage fetuses, and the transgenes could not be detected. Our results indicate that it is possible to transfect in vivo preimplantation embryos, although the success rate appears to be relatively low and gene expression is transient. This technology may provide a new method for manipulating preimplantation embryos in vivo, by using, for example, Cre-mediated conditional DNA recombination.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22631885     DOI: 10.3109/19396368.2012.688088

Source DB:  PubMed          Journal:  Syst Biol Reprod Med        ISSN: 1939-6368            Impact factor:   3.061


  3 in total

1.  GONAD: A Novel CRISPR/Cas9 Genome Editing Method that Does Not Require Ex Vivo Handling of Embryos.

Authors:  Channabasavaiah B Gurumurthy; Gou Takahashi; Kenta Wada; Hiromi Miura; Masahiro Sato; Masato Ohtsuka
Journal:  Curr Protoc Hum Genet       Date:  2016-01-01

2.  GONAD: Genome-editing via Oviductal Nucleic Acids Delivery system: a novel microinjection independent genome engineering method in mice.

Authors:  Gou Takahashi; Channabasavaiah B Gurumurthy; Kenta Wada; Hiromi Miura; Masahiro Sato; Masato Ohtsuka
Journal:  Sci Rep       Date:  2015-06-22       Impact factor: 4.379

Review 3.  Nucleic acids delivery methods for genome editing in zygotes and embryos: the old, the new, and the old-new.

Authors:  Masahiro Sato; Masato Ohtsuka; Satoshi Watanabe; Channabasavaiah B Gurumurthy
Journal:  Biol Direct       Date:  2016-03-31       Impact factor: 4.540

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.